Enhancing immune responses using suicidal DNA vaccines

Nature Biotechnology

Volumn 16, Issue 6, 1998, Pages 562-565

  Berglund, Peter ^a,c   Smerdou, Cristian ^a,b   Fleeton, Marina N ^a,b   Tubulekas, Loannis ^a,b   Liljeström, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Applied immunology; Influenza; Semliki Forest virus

Indexed keywords

DNA VACCINE; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INFECTION RESISTANCE; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CELL LINE; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; DNA, RECOMBINANT; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS; KIDNEY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; REPLICON; SEMLIKI FOREST VIRUS; VACCINES, DNA;

ALPHAVIRUS; ANIMALIA; INFLUENZA VIRUS; SEMLIKI FOREST VIRUS;

EID: 0031838647     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0698-562     Document Type: Article

References (43)

1. Donnelly, J.J., Ulmer, J.B., Shiver, J.W., and LJu, MA 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.
2. Robinson, H.L, Lu, S., Feltquate, D.M., Torres, C.T., Richmond, J., Boyle, C.M. et al. 1996. DNA vaccines. AIDS Res. Hum. Retroviruses 12:455-457.
3. Tang, D.C., De Vit, M., and Johnston, SA 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
4. Davis, H.L, Michel, M.L, and Whalen, R.G. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet 2:1847-1851.
5. Zarozinski, C.C., Fynan, E.F., Selin, L.K., Robinson, H.L, and Welsh, P.M. 1995. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:401(W017.
6. Fu, T.-M., Fn'edman, A., Ulmer, J.B., Uu, M A, and Donnelly, J.J. 1997. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of Influenza virus nucleoproteins induced by DNA immunization. J. Virol. 71:2715-2721.
7. Ulmer, J.B.,DonnelIy, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L, Dwarki, V.J. et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
8. Xiang, Z.Q., Spitalnik, S., Tran, M., Wunner, W.H., Cheng, J., and Ertl, H.C.J. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132-140.
9. Robinson, H.L, Hunt, LA, and Webster, R.G. 1993. Protection against a lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DMA. Vaccine 11:957-960.
10. Letvin, N.L, Montefiori, D.C., Yasutomi, Y, Perry, H.C., Davies, M.E., Lekutis, C. et al. 1997. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94:9378-9383.
11. Wolff, JA, Malone. R.W., Williams, P., Chong, W., Acsadi, G., Jani, A. et al. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
12. Wolff, JA, Ludtke, J.J., Acsadi, G., Williams, P., and Jani, A. 1992. Long-term persistence of plasmid DMA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
13. Alferink, J., Schittek, B., Schonrich, G., Hämmerling, G.J., and Arnold, B. 1995. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int. Immunol. 7:331-336.
14. Ferber, I., Schonrich, G., Schenkel, J., Mellor, A.L, Hämmerling, G.J., and Arnold, B. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674-676.
15. Nichols, W.W., Ledwith, B.J., Manam, S.V., and Troilo, P.J. 1995. Potential DMA vaccine integration into host cell genome. Ann. NYAcad. Sci. 772:30-39.
16. Mor, G., Yamschchikov, G., Sedagh, M., Takeno, M., Wang, R., Houghten, R A et al. 1996. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J. Clin. Invest. 98:2700-2705.
17. Zhou, X., Berglund, P., Zhao, H., LJljeström, P., and Jondal, M. 1995. Generation of cytotoxic and humoral immune responses using non-replicative recombinant Semliki Forest virus. Proc. Watt Acad. Sci. USA 92:3009-3013.
18. Zhou, X., Berglund, P., Rhodes, G., Parker, S.E., Jondal, M., and üljeström, P. 1994. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12:1510-1514.
19. Tubulekas, I., Berglund, P., Reeton, M., and üljeström, R1997. Alphavirus expression vectors and their use as recombinant vaccines-a minireview. Gene 190:191-195.
20. Dubensky, T.W. Jr., Driver, DA, Polo, J.M., Belli, BA, Latham, E.M., Ibanez, C.E. et al. 1996. Sindbis virus DMA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Wol. 70:508-519.
21. Herweijer, H., Latendresse, J.S., Williams, P., Zhang, G., Danko, I., Schlesinger, S. et al. 1995. A plasmid-based self-amplifying Sindbis virus vector. Hum. Gene Ther. 6:1161-1167.
22. Frolov, I. and Schlesinger, S. 1994. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogeneticity in BHK cells. J.WroJ. 68:1721-1727.
23. Glasgow, G.M., McGee, M.M., Sheahan, B.J., and Atkins, G.J. 1997. Death mechanisms in cultured cells infected by Semliki Forest virus. J. Gen. Virol. 78:1559-1563.
24. Davis, N.L, Brown, K.W., and Johnston, R.E. 1996. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Wol. 70:3781-3787.
25. Pushko, P., Parker, M., Ludwig, G.V., Davis, N.L, Johnstone, R.E., and Smith, J.F. 1997. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus-expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239:389-401.
26. Liljeström, P. and Garoff, H. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356-1361.
27. Sjöberg, M.E., Suomalainen, M., and Garoff, H. 1994. A significantly improved Semliki Forest virus expression system based on translational enhancer segments from the viral capsid gene. Bio/Technology 12:1127-1131.
28. Levine, B., Huang, Q., Isaacs, J.T., Reed, J.C., Griffin. D.E., and Hardwick, J.M. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739-742.
29. Zhang, J., Asselin-Paturel, C., Bex, F., Bernhard, J., Chehimi, J., Willems, F. et al. 1997. Cloning of IL-12 p40 and p35 DNA into the Semliki Forest virus vector, expression of IL-12 in human tumor cells. Gene Ther. 4:367-374.
30. Raz, E., Carson, DA, Parker, S.E., Parr. T.B., Abai, A.M., Aichinger, G. et al. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Watt Acad. Sei USA 91:9519-9523.
31. Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A, Margalith, M. et al. 1993. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4:419-431.
32. Hariharan, M.J., Driver, DA, Townsend, K., Brumm, D., Polo, J.M., Belli, B A et al. 1998. DNA immunization against Herpes Simplex virus: Enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72:950-958.
33. Brandt, E.R., U'nnane, A.W., and Devenish, R.J. 1994. Expression of IFN A genes in subpopulations of peripheral blood cells. Br. J. Haematol. 86:717-725.
34. Kaluza, G., Lell, G., Reinacher, M., Stitz, L, and Willems, W.R. 1987. Neurogenic spread of Semliki Forest virus in mice. Arch. Virol. 93:97-110.
35. Gates, M.C., Sheahan, B.J., and Atkins, G.J. 1984. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice. J. Gen. Virol. 65:73-80.
36. Donnelly, S.M., Sheahan, B.J., and Atkins, G.J. 1997. Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol. Appl. Neurobiol. 23:235-241.
37. Krieg, A.M., Yi, A-K., Schorr, J., and Davis, H.L 1998. The role of CpG dinucleotides in DMA vaccines. Trends Microbiol. 6:23-26.
38. Donnelly, J.J., Ulmer, J.B., and Uu, MA 1997. DNA vaccines. Life Sci. 60:163-172.
39. Berglund, R, Sjöberg, M., Atkins, G.J., Sheahan, B.J., Garoff, H., and Üljeström, P. 1993. Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio/Technology 11:916-920.
40. Liljeström, P. and Garoff, H. 1994. Expression of proteins using Semliki Forest virus vectors, 16.20.11-16.20.16 in Current Protocols in Molecular Biology, Vol. 2. Ausubel, P.M., Brent, R., Kingston, R.E., Moore, D.D., Smith, JA, Seidman, J.G. et al. (eds.). Greene Publishing Associates and Wiley Interscience, New York.
41. Rhodes, G.H., Dwarki, VJ., Abai, A.M., Feigner, J., Feigner, P.L, Gromkovski. S.H. et al. 1993. Injection of expression vectors containing viral genes induces cellular, humoral and protective immunity, pp. 137-141 in Vaccines 93. Ginsberg, H.S., Brown, R, Chanock, R.M., and Lemer, RA (eds.). Cold Spring Harbor Press, Cold Spring Harbor, NY.
42. Taswell, C. 1981. Limiting dilution assay for the determination of imunocompetent cell frequencies. J. Immunol. 126:1614-1619.
43. Rötzschke, O., Falk, K., Dere, K., Schild, H, Norda, M., Metzger, J. et al. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252-254.